Mater Pathology

Important information and updates

Mater Pathology's latest developments, information and news:

Introducing ANCA and anti-GBM testing by Mater Pathology

From 1 December 2016, Mater Pathology Immunbology Department will begin performing ANCA (anti-neurtrophil cytoplasmic antibody) immunolfluorescence and MPO/Pr3 ANCA testing for the the diagnosis of ANCA associated small vessel Vasculitis and GBM antibodies for the diagnosis of Goodpasture's/Anti-GBM disease (currently resported by Pathology Queensland).

Find out what this means for clinicians.

View further news, information and updates


Royal College of Pathologists Australia logo     

Accredited for compliance with NPAAC Standards and ISO 15189